United Therapeutics Corp.
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
FY2009
Asset Breakdown FY2010
Total Assets: $1.43B
Liabilities Breakdown FY2010
Total Liabilities: $536.9M
Asset Breakdown
Total Assets: $1.43B
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $252.2M | 17.6% |
| Accounts Receivable | $73.7M | 5.1% |
| Inventory | $35.5M | 2.5% |
| Property, Plant & Equipment | $306.0M | 21.4% |
| Goodwill | $2.5M | 0.2% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $761.7M | 53.2% |
Liabilities Breakdown
Total Liabilities: $536.9M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $16.1M | 3.0% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $520.7M | 97.0% |